Patent Baristas

In another sign that Roche needs to act quickly to preserve their intellectual property rights, a recent report by the BBC says Taiwan has responded to rampant bird flu paranoia by starting work on its own version of the anti-viral drug, Tamiflu, without waiting for a license to the patent rights from Roche. Taiwan officials […]

In a new twist in the Tamiflu drama being playing out across the globe, it’s now being reported that Gilead Sciences, Inc., the developer of Tamiflu, is believed to have terminated its agreement with Roche, which has the exclusive marketing right on the drug. Now, generic manufacturers like India’s Cipla Ltd., are wondering who holds […]

As we’ve mentioned before, the entire planet seems to be getting jittery over the avian flu virus. Now, Roche AG has agreed to meet with generic manufacturers Teva Pharmaceutical Industries Ltd., Barr Pharmaceuticals Inc., Mylan Laboratories Inc. and Ranbaxy Laboratories Ltd. to license its patent and increase production of its antiviral drug Tamiflu (oseltamivir) to […]

The United States Court of Appeals for the Federal Circuit took up the question of internal use of an invention as it relates to a public use in determining patentability in Invitrogen Corp. v. Biocrest Mfg., L.P., Stratagene Holding Corp., & Stratagene, Inc., 04-1273, -1274. On an earlier remand from the CAFC, the District Court, […]

Taiwan has come out saying it could produce up to a million doses of anti-influenza drug Tamiflu within months to counter a possible bird flu pandemic if it obtains a license from the drug’s manufacturers. Roche has said it is willing to share production with governments or other companies as fears of a pandemic rise […]

Bill Heinze over at I/P Updates noted an article in Managing Intellectual Property on October 18, 2005, where USPTO Commissioner Jon Dudas is quoted as calling on companies and patent prosecutors to help the Office improve the timeliness and quality of patent examinations by calling for “a reduction in the number of continuations, fewer claims […]

The USPTO published revised procedures for presenting preliminary amendments upon filing of a patent application. If on filing an application, an applicant includes a preliminary amendment to the specification, then the publication of the application must be based on the specification and drawings as amended by the preliminary amendment. The only format for an amendment […]

Blawg Review #28 is up and running at J. Craig Williams’ blog site May It Please The Court. There were a number of blog sites mentioned we haven’t seen before. We particularly enjoyed reading about the USPTO’s decision in the Eolas matter finding the patent of Eolas’ web browsing technology valid and will issue a […]